Endometrial cancer is the most frequently diagnosed malignancy of the female genital tract and the sixth most common cancer in women globally. Finding a simple, non-invasive test that identifies endometrial cancer effectively could transform the way the disease is detected and improve patient care.
Given the function of the bladder, and its proximity to the urinary tract, urine as a sample type is particularly attractive as it can contain potential biomarkers for bladder cancer detection.
Given the challenges with some traditional screening and detection methods, researchers are continuously exploring alternative methods to detect cancer types.
Vaccines play a critical role in protecting people against disease. HPV vaccination is primarily used for young girls, but is also recommended for boys. This blog explains the potential of HPV vaccination in reducing HPV-related cancers for girls and boys.
Current methods for PCa detection lack specificity Prostate cancer (PCa) is the second most frequently diagnosed cancer and a major cause of death in men worldwide. Testing for prostate-specific antigen (PSA) in blood, the current gold standard for PCa screening has limitations. Other non-cancerous...
DNA methylation-based biomarkers have shown potential in disease detection and monitoring . This blog highlights areas in which DNA methylation could support cancer research and examples of biomarkers that are being investigated for various cancer types. Abnormal DNA methylation is common in cancer...
Did you know a urine preservative can help maintain the integrity and original composition of urine samples. Read our latest blog to know 3 reasons why urine preservation is needed.
Urine as a liquid biopsy is attractive in the field of gynecological cancer research. Urine in conjunction with other diagnostic tools could help screen for these diseases more quickly and accurately, allowing treatment to start earlier, especially during a time where healthcare systems are stressed, but even beyond.
Ovarian cancer (OC) is the seventh most common malignancy among women worldwide. More than 70% of women present the disease at an advanced stage, making the cancer type the most lethal of all gynecological malignancies.
Given the disproportionate impact of STIs and HIV on the same populations, more convenient STI testing methods are needed to reach groups at risk. PrEP provides the opportunity to reach people at highest HIV and STI risk, expanding HIV prevention and optimizing STI services. Urine has shown to be a more accepted and effective sample type to detect several STIs.
On International Day of Women and Girls in Science, Novosanis celebrates all women that contribute to this field. Read our blog, where we highlight the work of key women scientists as well as share some insights into our team!
Cancer screening rates have significantly dropped due to the COVID-19 pandemic. Alternative sampling methods are essential to continue healthcare practices in these challenging times. Urine as a sample type has shown great potential especially for cervical cancer screening
Novosanis
